ArticleToxicology and applied pharmacology2025
DNA damage response inhibition is an early event in cadmium-induced breast carcinogenesis.
Article in Toxicology and applied pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Induction of aneuploidy by the metal-chelating agent neodecanoid acid in mammalian cells in vitro.Archives of toxicology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Triple-negative breast cancer (TNBC) is an aggressive form of breast cancer with few treatment options that disproportionately affects individuals with Breast Cancer 1 (BRCA1) gene mutations and young, non-Hispanic Black women. However, BRCA1 mutation frequencies are similar among women from all races/ethnicities, with the exception of Ashkenazi Jewish women, suggesting that gene-environment interactions contribute to TNBC disparities. Environmental cadmium (Cd) exposure is positively associated with breast cancer and Cd accumulates in human breast tumors compared to normal adjacent tissue. Previous work determined that Cd exposure promotes MCF10A cell malignant transformation after 40 weeks. Here, we report that chronic Cd exposure dysregulates essential metal homeostasis and promotes significant accumulation of DNA double-strand breaks (DSBs). Moreover, phosphorylation of Breast Cancer gene 1 (BRCA1) and Tumor Protein P53 (TP53) at critical sites (pSer1524 and pSer392, respectively) required for DNA damage response (DDR) signaling were significantly reduced by chronic Cd exposure in pre-malignant MCF10A cells. We also demonstrate significantly lower cyclin dependent kinase inhibitor 1A (CDKN1A) expression and increased RB1 phosphorylation (pSer807/811), providing evidence for reduced BRCA1 and/or TP53 function in cells chronically exposed to Cd. Our results suggest that chronic Cd exposure inhibits DDR signaling both indirectly by depletion of essential metals and by inhibition of DDR zinc finger protein activation, providing novel mechanisms for environmentally-induced TNBC. As a result, our study provides a molecular mechanism that may contribute to TNBC disparities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.